Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 2071567

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 2071567

EU5 Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

PUBLISHED:
PAGES: 220 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

GlobalData's "EU5 Orthobiologics Outlook to 2033" is a comprehensive databook report, covering key market data on the EU5 Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The EU5 Orthobiologics Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the EU5 Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

EU5 Orthobiologics is segmented as follows -

  • Cartilage Repair
  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

The EU5 Orthobiologics Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME21840CRDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Orthobiologics Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, EU5

  • 3.1 Orthobiologics Market, EU5, Revenue ($m), 2018-2033
  • 3.2 Orthobiologics Market, EU5, Revenue ($m), 2018-2033
  • 3.3 Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • 3.4 Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • 3.5 Orthobiologics Market, EU5, Company Share by Revenue ($m), 2025

4 Orthobiologics Market, France

  • 4.1 Orthobiologics Market, France, Revenue ($m), 2018-2033
    • 4.1.1 Bone Grafts and Substitutes Market, France, Revenue ($m), by Segment, 2018-2033
    • 4.1.2 Bone Growth Stimulators Market, France, Revenue ($m), by Segment, 2018-2033
    • 4.1.3 Cartilage Repair Market, France, Revenue ($m), by Segment, 2018-2033
    • 4.1.4 Soft Tissue Biologics Market, France, Revenue ($m), by Segment, 2018-2033
    • 4.1.5 Viscosupplementation Market, France, Revenue ($m), by Segment, 2018-2033
  • 4.2 Orthobiologics Market, France, Volume (Units), 2018-2033
    • 4.2.1 Bone Grafts and Substitutes Market, France, Volume (Units), by Segment, 2018-2033
    • 4.2.2 Bone Growth Stimulators Market, France, Volume (Units), by Segment, 2018-2033
    • 4.2.3 Cartilage Repair Market, France, Volume (Units), by Segment, 2018-2033
    • 4.2.4 Soft Tissue Biologics Market, France, Volume (Units), by Segment, 2018-2033
    • 4.2.5 Viscosupplementation Market, France, Volume (Units), by Segment, 2018-2033
  • 4.3 Orthobiologics Market, France, Average Price ($), 2018-2033
  • 4.4 Orthobiologics Market, France, Company Share by Revenue ($m), 2025

5 Orthobiologics Market, Germany

  • 5.1 Orthobiologics Market, Germany, Revenue ($m), 2018-2033
    • 5.1.1 Bone Grafts and Substitutes Market, Germany, Revenue ($m), by Segment, 2018-2033
    • 5.1.2 Bone Growth Stimulators Market, Germany, Revenue ($m), by Segment, 2018-2033
    • 5.1.3 Cartilage Repair Market, Germany, Revenue ($m), by Segment, 2018-2033
    • 5.1.4 Soft Tissue Biologics Market, Germany, Revenue ($m), by Segment, 2018-2033
    • 5.1.5 Viscosupplementation Market, Germany, Revenue ($m), by Segment, 2018-2033
  • 5.2 Orthobiologics Market, Germany, Volume (Units), 2018-2033
    • 5.2.1 Bone Grafts and Substitutes Market, Germany, Volume (Units), by Segment, 2018-2033
    • 5.2.2 Bone Growth Stimulators Market, Germany, Volume (Units), by Segment, 2018-2033
    • 5.2.3 Cartilage Repair Market, Germany, Volume (Units), by Segment, 2018-2033
    • 5.2.4 Soft Tissue Biologics Market, Germany, Volume (Units), by Segment, 2018-2033
    • 5.2.5 Viscosupplementation Market, Germany, Volume (Units), by Segment, 2018-2033
  • 5.3 Orthobiologics Market, Germany, Average Price ($), 2018-2033
  • 5.4 Orthobiologics Market, Germany, Company Share by Revenue ($m), 2025

6 Orthobiologics Market, Italy

  • 6.1 Orthobiologics Market, Italy, Revenue ($m), 2018-2033
    • 6.1.1 Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 6.1.2 Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 6.1.3 Cartilage Repair Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 6.1.4 Soft Tissue Biologics Market, Italy, Revenue ($m), by Segment, 2018-2033
    • 6.1.5 Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2018-2033
  • 6.2 Orthobiologics Market, Italy, Volume (Units), 2018-2033
    • 6.2.1 Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2018-2033
    • 6.2.2 Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2018-2033
    • 6.2.3 Cartilage Repair Market, Italy, Volume (Units), by Segment, 2018-2033
    • 6.2.4 Soft Tissue Biologics Market, Italy, Volume (Units), by Segment, 2018-2033
    • 6.2.5 Viscosupplementation Market, Italy, Volume (Units), by Segment, 2018-2033
  • 6.3 Orthobiologics Market, Italy, Average Price ($), 2018-2033
  • 6.4 Orthobiologics Market, Italy, Company Share by Revenue ($m), 2025

7 Orthobiologics Market, Spain

  • 7.1 Orthobiologics Market, Spain, Revenue ($m), 2018-2033
    • 7.1.1 Bone Grafts and Substitutes Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 7.1.2 Bone Growth Stimulators Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 7.1.3 Cartilage Repair Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 7.1.4 Soft Tissue Biologics Market, Spain, Revenue ($m), by Segment, 2018-2033
    • 7.1.5 Viscosupplementation Market, Spain, Revenue ($m), by Segment, 2018-2033
  • 7.2 Orthobiologics Market, Spain, Volume (Units), 2018-2033
    • 7.2.1 Bone Grafts and Substitutes Market, Spain, Volume (Units), by Segment, 2018-2033
    • 7.2.2 Bone Growth Stimulators Market, Spain, Volume (Units), by Segment, 2018-2033
    • 7.2.3 Cartilage Repair Market, Spain, Volume (Units), by Segment, 2018-2033
    • 7.2.4 Soft Tissue Biologics Market, Spain, Volume (Units), by Segment, 2018-2033
    • 7.2.5 Viscosupplementation Market, Spain, Volume (Units), by Segment, 2018-2033
  • 7.3 Orthobiologics Market, Spain, Average Price ($), 2018-2033
  • 7.4 Orthobiologics Market, Spain, Company Share by Revenue ($m), 2025

8 Orthobiologics Market, United Kingdom

  • 8.1 Orthobiologics Market, United Kingdom, Revenue ($m), 2018-2033
    • 8.1.1 Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 8.1.2 Bone Growth Stimulators Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 8.1.3 Cartilage Repair Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 8.1.4 Soft Tissue Biologics Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
    • 8.1.5 Viscosupplementation Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
  • 8.2 Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
    • 8.2.1 Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 8.2.2 Bone Growth Stimulators Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 8.2.3 Cartilage Repair Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 8.2.4 Soft Tissue Biologics Market, United Kingdom, Volume (Units), by Segment, 2018-2033
    • 8.2.5 Viscosupplementation Market, United Kingdom, Volume (Units), by Segment, 2018-2033
  • 8.3 Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
  • 8.4 Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2025

9 Overview of Key Companies in EU5 Orthobiologics Market

  • 9.1 Medtronic Plc
    • 9.1.1 Company Overview
  • 9.2 Sanofi
    • 9.2.1 Company Overview
  • 9.3 Enovis Corp
    • 9.3.1 Company Overview
  • 9.4 Fidia farmaceutici SpA
    • 9.4.1 Company Overview
  • 9.5 Stryker Corp
    • 9.5.1 Company Overview
  • 9.6 Arthrex Inc
    • 9.6.1 Company Overview
  • 9.7 Zimmer Biomet Holdings Inc
    • 9.7.1 Company Overview
  • 9.8 Orthofix Holdings Inc
    • 9.8.1 Company Overview
  • 9.9 Smith & Nephew Plc
    • 9.9.1 Company Overview
  • 9.10 Bioventus Inc
    • 9.10.1 Company Overview
  • 9.11 DePuy Synthes Inc
    • 9.11.1 Company Overview
  • 9.12 Orthofix Medical Inc
    • 9.12.1 Company Overview
  • 9.13 LifeNet Health Inc
    • 9.13.1 Company Overview
  • 9.14 Ferring Pharmaceuticals AS
    • 9.14.1 Company Overview
  • 9.15 Highridge Inc
    • 9.15.1 Company Overview
  • 9.16 Globus Medical Inc
    • 9.16.1 Company Overview
  • 9.17 AlloSource
    • 9.17.1 Company Overview
  • 9.18 Anika Therapeutics Inc
    • 9.18.1 Company Overview
  • 9.19 CONMED Corp
    • 9.19.1 Company Overview
  • 9.20 Xtant Medical Holdings Inc
    • 9.20.1 Company Overview
  • 9.21 Avanos Medical Inc
    • 9.21.1 Company Overview

10 Orthobiologics Market Pipeline Products

11 Recent Developments

  • 11.1 Corporate Communications
    • 11.1.1 Nov 21, 2025: Surgeons Collaborate to Treat War Injuries in Ukraine
    • 11.1.2 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures
    • 11.1.3 Nov 15, 2025: [COA2025] Aikang Medical Excels on Day Two with Six Events Highlighting Global Orthopedic Expertise
    • 11.1.4 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%
    • 11.1.5 Nov 06, 2025: Paho Promotes Interregional Cooperation to Strengthen Health Autonomy in Latin America and the Caribbean
    • 11.1.6 Oct 30, 2025: Regenerative Treatments: PRP, Stem Cell, Exosome, and Hyaluronic Acid
    • 11.1.7 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho
    • 11.1.8 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus
    • 11.1.9 Oct 07, 2025: Allegro Demonstrates Injectable Hydrogel's Shock-Absorbing Capacity for Osteoarthritis
    • 11.1.10 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects
    • 11.1.11 Oct 03, 2025: Manufacturer Of Biodegradable Implants Secures 30 Million Rubles From Moscow Venture Fund And Global Market Access
    • 11.1.12 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart
    • 11.1.13 Sep 16, 2025: MUDr. Martin Kloub Appointed Associate Professor for Surgical Atlas
    • 11.1.14 Aug 19, 2025: Medtronic Appoints John Groetelaars and Bill Jellison as Independent Directors
    • 11.1.15 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
    • 11.1.16 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
  • 11.2 Financial Announcements
    • 11.2.1 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%
    • 11.2.2 May 07, 2025: Medtronic to Announce Financial Results for Its Fourth Quarter and Full Fiscal Year 2025
  • 11.3 Government and Public Interest
    • 11.3.1 Sep 05, 2025: 107th Meeting of the Economic Council of CIS Held in Dushanbe
    • 11.3.2 Sep 02, 2025: Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025
    • 11.3.3 Aug 29, 2025: Medtronic Executives to Speak at Upcoming Investor Conferences
    • 11.3.4 May 23, 2025: Medtronic Chairman and CEO Geoff Martha to Speak at Bernstein's Strategic Decisions Conference
  • 11.4 Other Significant Developments
    • 11.4.1 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures
    • 11.4.2 Oct 28, 2025: Aap Implantate AG Reports Strong Q3 Growth
    • 11.4.3 Oct 23, 2025: Integrum Announces Organizational Restructuring to Strengthen Its Commercial Focus
    • 11.4.4 Oct 17, 2025: University Hospital Vienna And MedUni Vienna Choose Innovative TAPE Method
    • 11.4.5 Oct 03, 2025: Manufacturer Of Biodegradable Implants Secures 30 Million Rubles From Moscow Venture Fund And Global Market Access
  • 11.5 Product News
    • 11.5.1 Nov 19, 2025: LEM Surgical Completes First U.S. Clinical Procedures
    • 11.5.2 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%
    • 11.5.3 Nov 13, 2025: Implanet Signs Partnership Agreement With 8i Robotics Inc. For Clinical Evaluation Of Robotic Spine Surgery System
    • 11.5.4 Nov 13, 2025: Icotec Receives FDA Clearance for CMORE CT System, Expanding BlackArmor Engineered Carbon/PEEK Technology
    • 11.5.5 Oct 29, 2025: Joint Replacement: AOK Rheinland-Pfalz/Saarland Partners with ActiveTEP
    • 11.5.6 Oct 27, 2025: Mineral Nanotube Coating Extends Lifespan of Biodegradable Implants
    • 11.5.7 Oct 23, 2025: ABRYSVO Receives Expanded Public Funding Across Canadian Provinces for 2025-2026 RSV Season
    • 11.5.8 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions
    • 11.5.9 Oct 07, 2025: Allegro Demonstrates Injectable Hydrogel's Shock-Absorbing Capacity for Osteoarthritis
    • 11.5.10 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects
    • 11.5.11 Oct 01, 2025: Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment
    • 11.5.12 Oct 01, 2025: FDA Grants Clearance For Planmed XFI Full-Body Weight-Bearing CT Scanner
    • 11.5.13 Sep 18, 2025: Brainlab Secures FDA 510(k) Clearance and Launches Spine Mixed Reality Navigation
    • 11.5.14 Sep 17, 2025: First Touch CMC 1 Prosthesis Implanted in the United States
    • 11.5.15 Sep 16, 2025: HM Malaga First Private Hospital In Andalusia To Use 3D Spine Surgery Navigator
    • 11.5.16 Sep 15, 2025: Bonesupport Holding AB (publ): Strong CERAMENT Results Presented
    • 11.5.17 Sep 12, 2025: Bioretec Provides Update on RemeOs DrillPin Commercialization
  • 11.6 Research And Development
    • 11.6.1 Oct 27, 2025: Mineral Nanotube Coating Extends Lifespan of Biodegradable Implants
    • 11.6.2 Oct 07, 2025: Bip Proof Programme Funds Innovative I3S Projects
  • 11.7 Strategy And Business Planning
    • 11.7.1 Nov 14, 2025: PetVivo Reports Fiscal Q2 2026 Results With Revenues Up 50%
    • 11.7.2 Nov 03, 2025: LISI Group Confirms Sale of LISI MEDICAL Division to SK Capital
    • 11.7.3 Oct 29, 2025: Joint Replacement: AOK Rheinland-Pfalz/Saarland Partners with ActiveTEP
    • 11.7.4 Oct 28, 2025: Alira Health Advises Andera Partners On Strategic Investment In Adler Ortho
    • 11.7.5 Oct 28, 2025: Scoliosis Research Society Forms New Partnership with EUROSPINE
    • 11.7.6 Oct 21, 2025: Uel And Mbst Collaborate On Health Research
    • 11.7.7 Oct 20, 2025: Biedermann Motech Expands MOSS!MODULARITY Platform with New Product Introductions
    • 11.7.8 Oct 02, 2025: Gimv Invests CHF 28 Million in Spineart
    • 11.7.9 Sep 17, 2025: Keensight Capital Acquires Majority Stake in Isto Biologics from Thompson Street Capital Partners
    • 11.7.10 Sep 16, 2025: HM Malaga First Private Hospital In Andalusia To Use 3D Spine Surgery Navigator

12 Appendix

  • 12.1 Research Methodology
    • 12.1.1 Coverage
    • 12.1.2 Secondary Research
    • 12.1.3 Primary Research
    • 12.1.4 Market Modeling and Forecasting
    • 12.1.5 Company Share Analysis
    • 12.1.6 Benchmarking
  • 12.2 GlobalData Consulting
  • 12.3 Contact Us
  • 12.4 Disclaimer
Product Code: GDME21840CRDB

List of Table

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Orthobiologics Market, EU5, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • Table 4: Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • Table 5: Orthobiologics Market, EU5, Company Share by Revenue ($m), 2025
  • Table 6: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 7: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 8: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 9: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 10: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 11: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033
  • Table 12: Orthobiologics Market, France, Volume (Units), 2018-2033
  • Table 13: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033
  • Table 14: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033
  • Table 15: Cartilage Repair Market, France, Volume (Units), 2018-2033
  • Table 16: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033
  • Table 17: Viscosupplementation Market, France, Volume (Units), 2018-2033
  • Table 18: Orthobiologics Market, France, Average Price ($), 2018-2033
  • Table 19: Orthobiologics Market, France, Company Share by Revenue ($m), 2025
  • Table 20: Orthobiologics Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 21: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 22: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 23: Cartilage Repair Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 24: Soft Tissue Biologics Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 25: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Table 26: Orthobiologics Market, Germany, Volume (Units), 2018-2033
  • Table 27: Bone Grafts and Substitutes Market, Germany, Volume (Units), 2018-2033
  • Table 28: Bone Growth Stimulators Market, Germany, Volume (Units), 2018-2033
  • Table 29: Cartilage Repair Market, Germany, Volume (Units), 2018-2033
  • Table 30: Soft Tissue Biologics Market, Germany, Volume (Units), 2018-2033
  • Table 31: Viscosupplementation Market, Germany, Volume (Units), 2018-2033
  • Table 32: Orthobiologics Market, Germany, Average Price ($), 2018-2033
  • Table 33: Orthobiologics Market, Germany, Company Share by Revenue ($m), 2025
  • Table 34: Orthobiologics Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 35: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 36: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 37: Cartilage Repair Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 38: Soft Tissue Biologics Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 39: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Table 40: Orthobiologics Market, Italy, Volume (Units), 2018-2033
  • Table 41: Bone Grafts and Substitutes Market, Italy, Volume (Units), 2018-2033
  • Table 42: Bone Growth Stimulators Market, Italy, Volume (Units), 2018-2033
  • Table 43: Cartilage Repair Market, Italy, Volume (Units), 2018-2033
  • Table 44: Soft Tissue Biologics Market, Italy, Volume (Units), 2018-2033
  • Table 45: Viscosupplementation Market, Italy, Volume (Units), 2018-2033
  • Table 46: Orthobiologics Market, Italy, Average Price ($), 2018-2033
  • Table 47: Orthobiologics Market, Italy, Company Share by Revenue ($m), 2025
  • Table 48: Orthobiologics Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 49: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 50: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 51: Cartilage Repair Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 52: Soft Tissue Biologics Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 53: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Table 54: Orthobiologics Market, Spain, Volume (Units), 2018-2033
  • Table 55: Bone Grafts and Substitutes Market, Spain, Volume (Units), 2018-2033
  • Table 56: Bone Growth Stimulators Market, Spain, Volume (Units), 2018-2033
  • Table 57: Cartilage Repair Market, Spain, Volume (Units), 2018-2033
  • Table 58: Soft Tissue Biologics Market, Spain, Volume (Units), 2018-2033
  • Table 59: Viscosupplementation Market, Spain, Volume (Units), 2018-2033
  • Table 60: Orthobiologics Market, Spain, Average Price ($), 2018-2033
  • Table 61: Orthobiologics Market, Spain, Company Share by Revenue ($m), 2025
  • Table 62: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 63: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 64: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 65: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 66: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 67: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Table 68: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
  • Table 69: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
  • Table 70: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
  • Table 71: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
  • Table 72: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
  • Table 73: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
  • Table 74: Orthobiologics Market, United Kingdom, Average Price ($), 2018-2033
  • Table 75: Orthobiologics Market, United Kingdom, Company Share by Revenue ($m), 2025
  • Table 76: Orthobiologics Market Pipeline Products
  • Table 77: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figure

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Orthobiologics Market, EU5, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • Figure 4: Orthobiologics Market, EU5, Volume (Units), 2018-2033
  • Figure 5: Orthobiologics Market, EU5, Company Share (%), 2025
  • Figure 6: Orthobiologics Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: Bone Grafts and Substitutes Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 8: Bone Growth Stimulators Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 9: Cartilage Repair Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 10: Soft Tissue Biologics Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 11: Viscosupplementation Market, France, Revenue ($m), USD Constant, 2018-2033
  • Figure 12: Orthobiologics Market, France, Volume (Units), 2018-2033
  • Figure 13: Bone Grafts and Substitutes Market, France, Volume (Units), 2018-2033
  • Figure 14: Bone Growth Stimulators Market, France, Volume (Units), 2018-2033
  • Figure 15: Cartilage Repair Market, France, Volume (Units), 2018-2033
  • Figure 16: Soft Tissue Biologics Market, France, Volume (Units), 2018-2033
  • Figure 17: Viscosupplementation Market, France, Volume (Units), 2018-2033
  • Figure 18: Orthobiologics Market, France, Company Share (%), 2025
  • Figure 19: Orthobiologics Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 20: Bone Grafts and Substitutes Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 21: Bone Growth Stimulators Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 22: Cartilage Repair Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 23: Soft Tissue Biologics Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 24: Viscosupplementation Market, Germany, Revenue ($m), USD Constant, 2018-2033
  • Figure 25: Orthobiologics Market, Germany, Volume (Units), 2018-2033
  • Figure 26: Bone Grafts and Substitutes Market, Germany, Volume (Units), 2018-2033
  • Figure 27: Bone Growth Stimulators Market, Germany, Volume (Units), 2018-2033
  • Figure 28: Cartilage Repair Market, Germany, Volume (Units), 2018-2033
  • Figure 29: Soft Tissue Biologics Market, Germany, Volume (Units), 2018-2033
  • Figure 30: Viscosupplementation Market, Germany, Volume (Units), 2018-2033
  • Figure 31: Orthobiologics Market, Germany, Company Share (%), 2025
  • Figure 32: Orthobiologics Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 33: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 34: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 35: Cartilage Repair Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 36: Soft Tissue Biologics Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 37: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, 2018-2033
  • Figure 38: Orthobiologics Market, Italy, Volume (Units), 2018-2033
  • Figure 39: Bone Grafts and Substitutes Market, Italy, Volume (Units), 2018-2033
  • Figure 40: Bone Growth Stimulators Market, Italy, Volume (Units), 2018-2033
  • Figure 41: Cartilage Repair Market, Italy, Volume (Units), 2018-2033
  • Figure 42: Soft Tissue Biologics Market, Italy, Volume (Units), 2018-2033
  • Figure 43: Viscosupplementation Market, Italy, Volume (Units), 2018-2033
  • Figure 44: Orthobiologics Market, Italy, Company Share (%), 2025
  • Figure 45: Orthobiologics Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 46: Bone Grafts and Substitutes Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 47: Bone Growth Stimulators Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 48: Cartilage Repair Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 49: Soft Tissue Biologics Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 50: Viscosupplementation Market, Spain, Revenue ($m), USD Constant, 2018-2033
  • Figure 51: Orthobiologics Market, Spain, Volume (Units), 2018-2033
  • Figure 52: Bone Grafts and Substitutes Market, Spain, Volume (Units), 2018-2033
  • Figure 53: Bone Growth Stimulators Market, Spain, Volume (Units), 2018-2033
  • Figure 54: Cartilage Repair Market, Spain, Volume (Units), 2018-2033
  • Figure 55: Soft Tissue Biologics Market, Spain, Volume (Units), 2018-2033
  • Figure 56: Viscosupplementation Market, Spain, Volume (Units), 2018-2033
  • Figure 57: Orthobiologics Market, Spain, Company Share (%), 2025
  • Figure 58: Orthobiologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 59: Bone Grafts and Substitutes Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 60: Bone Growth Stimulators Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 61: Cartilage Repair Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 62: Soft Tissue Biologics Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 63: Viscosupplementation Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
  • Figure 64: Orthobiologics Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 65: Bone Grafts and Substitutes Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 66: Bone Growth Stimulators Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 67: Cartilage Repair Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 68: Soft Tissue Biologics Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 69: Viscosupplementation Market, United Kingdom, Volume (Units), 2018-2033
  • Figure 70: Orthobiologics Market, United Kingdom, Company Share (%), 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!